Evidence of gadolinium deposits in neuronal tissues following intravenous (IV) gadolinium-based contrast agents have been found, researchers from the Mayo Clinic reported. Findings have been published ...
Bracco, a global leader in diagnostic imaging, today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Mason Frazier, M.D., associate professor in the University of Alabama at Birmingham’s Marnix E. Heersink School of Medicine’s Department of Radiology, says contrast imaging is important part of ...
To obtain optical molecular images that reflect changes in biomarker expression requires the ability to deliver contrast agents to cells and tissues of interest, as well as the ability to wash away ...
(RTTNews) - GE Healthcare said Monday that the U.S. Food and Drug Administration approved Clariscan, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE Healthcare portfolio ...
Contrast-enhanced mammography is a new imaging test that uses an IV contrast injection to help doctors detect breast cancer earlier in women with dense breasts. Why Elon Musk says saving for ...
Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE Healthcare portfolio of contrast media products “The ...
Berlex Laboratories has issued a nationwide recall of its intravenous X-ray contrast agent because some vials crystallized prior to injection. The voluntary recall, which affects a single lot of the ...
CHALFONT ST GILES, England--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results